Aarkstore - Acute Heart Failure - Pipeline Review, H1 2015

1
Aarkstore - Acute Heart Failure - Pipeline
Review, H1 2015
www.aarkstore.com
2
Summary

• Global Markets Directs, Acute Heart Failure -
  Pipeline Review, H1 2015, provides an
• overview of the Acute Heart Failures therapeutic
  pipeline.
• This Market Research Report provides
  comprehensive information on the therapeutic
• development for Acute Heart Failure, complete
  with comparative analysis at various stages,
• therapeutics assessment by drug target, mechanism
  of action (MoA), route of administration
• (RoA) and molecule type, along with latest
  updates, and featured news and press releases. It
• also reviews key players involved in the
  therapeutic development for Acute Heart Failure
  and
• special features on late-stage and discontinued
  projects.

www.aarkstore.com
3
Scope

• - The report provides a snapshot of the
  global therapeutic landscape of Acute Heart
  Failure- The report reviews key pipeline
  products under drug profile section which
  includes, product description, MoA and RD brief,
  licensing and collaboration details other
  developmental activities - The report reviews
  key players involved in the therapeutics
  development for Acute Heart Failure and enlists
  all their major and minor projects- The report
  summarizes all the dormant and discontinued
  pipeline projects - A review of the Acute Heart
  Failure products under development by companies
  and universities/research institutes based on
  information derived from company and
  industry-specific sources- Pipeline products
  coverage based on various stages of development
  ranging from pre-registration till discovery and
  undisclosed stages- A detailed assessment of
  monotherapy and combination therapy pipeline
  projects

www.aarkstore.com
4
Reasons to buy

• - Provides strategically significant
  competitor information, analysis, and insights to
  formulate effective RD development strategies-
  Identify emerging players with potentially strong
  product portfolio and create effective
  counter-strategies to gain competitive
  advantage- Develop strategic initiatives by
  understanding the focus areas of leading
  companies- Identify and understand important and
  diverse types of therapeutics under development
  for Acute Heart Failure- Plan mergers and
  acquisitions effectively by identifying key
  players of the most promising pipeline- Devise
  corrective measures for pipeline projects by
  understanding Acute Heart Failure pipeline depth
  and focus of Indication therapeutics- Develop
  and design in-licensing and out-licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and Scope

www.aarkstore.com
5
Table of Contents

• Introduction 6
• Global Markets Direct Report Coverage
• Acute Heart Failure Overview
• Therapeutics Development
• Pipeline Products for Acute Heart Failure -
  Overview
• Pipeline Products for Acute Heart Failure -
  Comparative Analysis
• Acute Heart Failure - Therapeutics under
  Development by Companies
• Acute Heart Failure - Pipeline Products Glance
• Late Stage Products
• Clinical Stage Products

www.aarkstore.com
6
List Of Tables

• Number of Products under Development for Acute
  Heart Failure, H1 2015
• Number of Products under Development for Acute
  Heart Failure - Comparative Analysis, H1 2015
• Number of Products under Development by
  Companies, H1 2015
• Comparative Analysis by Late Stage Development,
  H1 2015
• Comparative Analysis by Clinical Stage
  Development, H1 2015
• Comparative Analysis by Early Stage Development,
  H1 2015
• Products under Development by Companies, H1 2015
• Acute Heart Failure - Pipeline by Amgen Inc., H1
  2015
• Acute Heart Failure - Pipeline by Anexon, Inc.,
  H1 2015

www.aarkstore.com
7
List Of Figures

• Number of Products under Development for Acute
  Heart Failure, H1 2015
• Number of Products under Development for Acute
  Heart Failure - Comparative Analysis, H1 2015
• Number of Products under Development by
  Companies, H1 2015
• Comparative Analysis by Late Stage Development,
  H1 2015
• Comparative Analysis by Clinical Stage
  Development, H1 2015
• Comparative Analysis by Early Stage Products, H1
  2015
• Assessment by Monotherapy Products, H1 2015
• Number of Products by Top 10 Targets, H1 2015
• Number of Products by Stage and Top 10 Targets,
  H1 2015
• Number of Products by Top 10 Mechanism of
  Actions, H1 2015

www.aarkstore.com
8
Related Market Research reports

• Ocular Hypertension - Pipeline Review, H1 2015
• Transitional Cell Cancer (Urothelial Cell Cancer)
  - Pipeline Review, H1 2015
• Actinic (Solar) Keratosis - Pipeline Review, H1
  2015
• Allergic Rhino-Conjunctivitis - Pipeline Review,
  H1 2015
• Severe Acute Respiratory Syndrome (SARS)
  Coronavirus Infection - Pipeline Review, H1 2015

www.aarkstore.com
9
Related Market Research reports

• Myocardial Ischemia - Pipeline Review, H1 2015
• Thalassemia - Pipeline Review, H1 2015
• Encephalomyelitis - Pipeline Review, H1 2015
• T-Cell Leukemia - Pipeline Review, H1 2015
• Peripheral T-Cell Lymphomas (PTCL) - Pipeline
  Review, H1 2015

www.aarkstore.com
10
Aarkstore - Acute Heart Failure - Pipeline
Review, H1 2015
Format Price
PDF 2000
Site Licence 4000
Enterprise Wide Licence  6000
www.aarkstore.com
11
Contact Us

• Office
• Office No. - 809, 8th Floor,
• B-Wing, Mahaavir Icon, 
• Plot No.- 89 90, Sector-15,
• CBD-Belapur, Navi Mumbai 400614, 
• Maharashtra, India.
• 24/7 Online Support 91 9987295242
• General Inquiries 91 - 22 2756 4953
• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog http//www.aarkstore.com/blog/
• Conference http//conference.aarkstore.com/
• News http//www.aarkstore.com/news

www.aarkstore.com